| 000 | 00863 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250518090841.0 | ||
| 264 | 0 | _c20200713 | |
| 008 | 202007s 0 0 eng d | ||
| 022 | _a1474-5488 | ||
| 024 | 7 |
_a10.1016/S1470-2045(20)30099-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aColeman, Robert | |
| 245 | 0 | 0 |
_aAdjuvant denosumab in early breast cancer - Authors' reply. _h[electronic resource] |
| 260 |
_bThe Lancet. Oncology _c03 2020 |
||
| 300 |
_ae125 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aAromatase Inhibitors |
| 650 | 0 | 4 | _aBone Density Conservation Agents |
| 650 | 0 | 4 | _aDenosumab |
| 700 | 1 | _aZhou, Ying | |
| 700 | 1 | _aChan, Arlene | |
| 773 | 0 |
_tThe Lancet. Oncology _gvol. 21 _gno. 3 _gp. e125 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1470-2045(20)30099-1 _zAvailable from publisher's website |
| 999 |
_c30708302 _d30708302 |
||